Browsing by Contributors Aroda, Vanita R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 8 of 8
PreviewIssue DateTitleContributor(s)
2018 JoCEM Volume 103 Issue 2 February (22).pdf.jpg2018Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention ProgramLe, A R T I C; Kim, Catherine; Aroda, Vanita R; Goldberg, Ronald B; Younes, Naji; Edelstein, Sharon L; Carrion-petersen, Marylou; Ehrmann, David A
2016 DC Volume 39 Issue 9 September (3).pdf.jpg2016Ef fi cacy and Safety of LixiLan , a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine , Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy : The LixiLan Proof-of-Concept Randomized TrialRosenstock, Julio; Diamant, Michaela; Aroda, Vanita R; Silvestre, Louise; Souhami, Elisabeth; Zhou, Tianyue; Perfetti, Riccardo; Fonseca, Vivian
2018 DiabetesCare Volume 41 Issue 2 February (9).pdf.jpg2018Ef fi cacy and Safety of Once- Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes ( SUSTAIN 3 ): Randomized Clinical TrialAhmann, Andrew J; Capehorn, Matthew; Charpentier, Guillaume; Dotta, Francesco; Henkel, Elena; Lingvay, Ildiko; Holst, Anders G; Annett, Miriam P; Aroda, Vanita R
2016 DC Volume 39 Issue 11 November (19).pdf.jpg2016Efficacy and Safety of LixiLan , a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin : The LixiLan-L Randomized TrialAroda, Vanita R; Rosenstock, Julio; Wysham, Carol; Unger, Jeffrey; Bellido, Diego
DiabetCare 2017 Volume 40 Issue 6 June (17).pdf.jpg2017Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972-1980.Aroda, Vanita R; Rosenstock, Julio; Wysham, Carol; Unger, Jeffrey; Bellido, Diego; Gonzalez-Galvez, Guillermo; Takami, Akane; Guo, Hailing; Niemoeller, Elisabeth; Souhami, Elisabeth; Bergenstal, Richard M; Investigators, LixiLan-L Trial
DiabetCare 2017 Volume 40 Issue 6 June (18).pdf.jpg2017Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972-1980.Aroda, Vanita R; Rosenstock, Julio; Wysham, Carol; Unger, Jeffrey; Bellido, Diego; Gonzalez-Galvez, Guillermo; Takami, Akane; Guo, Hailing; Niemoeller, Elisabeth; Souhami, Elisabeth; Bergenstal, Richard M; Investigators, LixiLan-L Trial
2016 JCEM Volume 101 Issue 4 April (55).pdf.jpg2016Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes StudyAroda, Vanita R; Edelstein, Sharon L; Goldberg, Ronald B; Knowler, William C; Marcovina, Santica M; Orchard, Trevor J; Bray, George A; Schade, David S; Temprosa, Marinella G; White, Neil H; Crandall, Jill P
2018 JoCEM Volume 103 Issue 5 May (36).pdf.jpg2018Response to Letter to the Editor: “ Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program ”Kim, Catherine; Aroda, Vanita R; Goldberg, Ronald B; Younes, Naji; Edelstein, Sharon L; Carrion-petersen, Mary Lou; Ehrmann, David A